Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.

Patients with ESRD undergoing TAVR have higher mortality and increased cost associated with their index hospitalization and are at increased risk of readmission within 90 days following TAVR.